CD8+ T‐cell memory in tumor immunology and immunotherapy
Abstract
Summary: The cellular and molecular mechanisms underlying the formation of distinct central, effector, and exhausted CD8+ T‐cell memory subsets were first described in the setting of acute and chronic viral diseases. The role of these T‐cell memory subsets are now being illuminated as relevant to the tumor‐bearing state. The generation and persistence of productive CD8+ T‐cell memory subsets is determined, in part, by antigen clearance, costimulation, responsiveness to homeostatic cytokines, and CD4+ T‐helper cells. By contrast, chronic exposure to antigen, negative costimulation, and immunomodulation by CD4+ T regulatory cells corrupt productive CD8+ T memory formation. It has become clear from human and mouse studies that the mere generation of CD8+ T‐cell memory is not a ‘surrogate marker’ for cancer vaccine efficacy. Some current cancer vaccine strategies may fail because they amplify, rather than correct or reset, the corrupted CD8+ memory population. Thus, much of the present effort in the development of vaccines for cancer and chronic infectious diseases is aimed at creating effective memory responses. Therapeutic vaccines for cancer and chronic infectious diseases may achieve consistent efficacy by ablation of the dysfunctional immune state and the provision of newly generated, non‐corrupted memory cells by adoptive cell transfer.
Citing Literature
Number of times cited: 213
- Theodore S. Nowicki, Siwen Hu-Lieskovan and Antoni Ribas, Mechanisms of Resistance to PD-1 and PD-L1 Blockade, The Cancer Journal, 24, 1, (47), (2018).
- M. Tabatabaei, N. Mosaffa, R. Ghods, S. Nikoo, S. Kazemnejad, M. Khanmohammadi, E. Mirzadeghan, A.R. Mahmoudi, M.R. Bolouri, R. Falak, B. Keshavarzi, M. Ramezani and A.H. Zarnani, Vaccination with human amniotic epithelial cells confer effective protection in a murine model of Colon adenocarcinoma, International Journal of Cancer, 142, 7, (1453-1466), (2017).
- Naohiro Seo, Yoshitaka Shirakura, Yoshiro Tahara, Fumiyasu Momose, Naozumi Harada, Hiroaki Ikeda, Kazunari Akiyoshi and Hiroshi Shiku, Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells, Nature Communications, 9, 1, (2018).
- Ruihua Ma, Tiantian Ji, Huafeng Zhang, Wenqian Dong, Xinfeng Chen, Pingwei Xu, Degao Chen, Xiaoyu Liang, Xiaonan Yin, Yuying Liu, Jingwei Ma, Ke Tang, Yi Zhang, Yue’e Peng, Jinzhi Lu, Yi Zhang, Xiaofeng Qin, Xuetao Cao, Yonghong Wan and Bo Huang, A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8+ T cells, Nature Cell Biology, 20, 1, (21), (2018).
- Huijuan Song, Pingsheng Huang, Jinfeng Niu, Gaona Shi, Chuangnian Zhang, Deling Kong and Weiwei Wang, Injectable polypeptide hydrogel for dual-delivery of antigen and TLR3 agonist to modulate dendritic cells in vivo and enhance potent cytotoxic T-lymphocyte response against melanoma, Biomaterials, 159, (119), (2018).
- Fatemeh S. Majedi, Mohammad Mahdi Hasani‐Sadrabadi, Yoko Kidani, Timothy J. Thauland, Alireza Moshaverinia, Manish J. Butte, Steven J. Bensinger and Louis‐S. Bouchard, Cytokine Secreting Microparticles Engineer the Fate and the Effector Functions of T‐Cells, Advanced Materials, 30, 7, (2018).
- Stefani Spranger, Daisy Dai, Brendan Horton and Thomas F. Gajewski, Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy, Cancer Cell, 31, 5, (711), (2017).
- Stefan Koeck, Johan Kern, Marit Zwierzina, Gabriele Gamerith, Edith Lorenz, Sieghart Sopper, Heinz Zwierzina and Arno Amann, The influence of stromal cells and tumor-microenvironment-derived cytokines and chemokines on CD3+CD8+ tumor infiltrating lymphocyte subpopulations, OncoImmunology, 6, 6, (e1323617), (2017).
- Anugraha Rajagopalan, Alexey Berezhnoy, Brett Schrand, Yvonne Puplampu-Dove and Eli Gilboa, Aptamer-Targeted Attenuation of IL-2 Signaling in CD8 + T Cells Enhances Antitumor Immunity, Molecular Therapy, 25, 1, (54), (2017).
- Felicity Stark, Risini Weeratna, Lise Deschatelets, Komal Gurnani, Renu Dudani, Michael McCluskie and Lakshmi Krishnan, An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma, Vaccines, 5, 4, (38), (2017).
- H. Shirota and D.M. Klinman, CpG Oligodeoxynucleotides as Adjuvants for Clinical Use, Immunopotentiators in Modern Vaccines, 10.1016/B978-0-12-804019-5.00009-8, (163-198), (2017).
- Sarbari Ghosh, Madhurima Sarkar, Tithi Ghosh, Ipsita Guha, Avishek Bhuniya, Akata Saha, Shayani Dasgupta, Subhasis Barik, Anamika Bose and Rathindranath Baral, Neem leaf glycoprotein generates superior tumor specific central memory CD8 + T cells than cyclophosphamide that averts post-surgery solid sarcoma recurrence, Vaccine, 35, 34, (4421), (2017).
- Yihui Rong, Zheng Dong, Zhixian Hong, Yun Jin, Wei Zhang, Bailong Zhang, Wei Mao, Huifang Kong, Chunping Wang, Bin Yang, Xudong Gao, Zhenyu Song, Susan E. Green, Haihan K. Song, Hongbo Wang and Yinying Lu, Reactivity toward Bifidobacterium longum and Enterococcus hirae demonstrate robust CD8 + T cell response and better prognosis in HBV-related hepatocellular carcinoma, Experimental Cell Research, 358, 2, (352), (2017).
- Zhao Li, Xiaobing Liu, Rongbin Guo and Pengfei Wang, TIM-3 plays a more important role than PD-1 in the functional impairments of cytotoxic T cells of malignant Schwannomas, Tumor Biology, 10.1177/1010428317698352, 39, 5, (101042831769835), (2017).
- William H. Bisson, Amedeo Amedei, Lorenzo Memeo, Stefano Forte and Dean W. Felsher, Tumor‐Promoting/Associated Inflammation and the Microenvironment: A State of the Science and New Horizons, Translational Toxicology and Therapeutics, (473-510), (2017).
- Sara Mastaglio, Pietro Genovese, Zulma Magnani, Eliana Ruggiero, Elisa Landoni, Barbara Camisa, Giulia Schiroli, Elena Provasi, Angelo Lombardo, Andreas Reik, Nicoletta Cieri, Martina Rocchi, Giacomo Oliveira, Giulia Escobar, Monica Casucci, Bernhard Gentner, Antonello Spinelli, Anna Mondino, Attilio Bondanza, Luca Vago, Maurilio Ponzoni, Fabio Ciceri, Michael C. Holmes, Luigi Naldini and Chiara Bonini, NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease, Blood, 130, 5, (606), (2017).
- Qiang Zhang, Brian T. Helfand, Benedito A. Carneiro, Weijun Qin, Ximing J. Yang, Chung Lee, Weipeng Zhang, Francis J. Giles, Massimo Cristofanilli and Timothy M. Kuzel, Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8 + T-cells Derived from Patients with Metastatic Castrate-resistant Disease, European Urology, (2017).
- Varsha Gupta, Manjistha Sengupta, Jaya Prakash and Baishnab Charan Tripathy, Molecular Therapeutics, Basic and Applied Aspects of Biotechnology, 10.1007/978-981-10-0875-7_11, (235-261), (2016).
- Canhua Jiang, Fulai Yuan, Jie Wang and Limeng Wu, Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages, Immunobiology, 222, 4, (651), (2017).
- Sun-Young Kim, Young-Woock Noh, Tae Heung Kang, Jung-Eun Kim, Sohyun Kim, Soong Ho Um, Doo-Byoung Oh, Yeong-Min Park and Yong Taik Lim, Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity, Biomaterials, 10.1016/j.biomaterials.2017.03.034, 130, (56-66), (2017).
- Johan Lundberg, Emma Jussing, Zhenjiang Liu, Qingda Meng, Martin Rao, Erik Samén, Rikard Grankvist, Peter Damberg, Ernest Dodoo, Markus Maeurer and Staffan Holmin, Safety of Intra-Arterial Injection with Tumor-Activated T Cells to the Rabbit Brain Evaluated by MRI and SPECT/CT, Cell Transplantation, 26, 2, (283), (2017).
- Elena Crespo, Loreto Fernandez, Marc Lúcia, Edoardo Melilli, Ricardo Lauzurica, Rosa Maria Penin, Ariadna Quer, Sergio Luque, Maria Quero, Anna Manonelles, Joan Torras, Josep Maria Cruzado, Laura Cañas, Josep Maria Grinyó and Oriol Bestard, Effector Antitumor and Regulatory T Cell Responses Influence the Development of Nonmelanoma Skin Cancer in Kidney Transplant Patients, Transplantation, 101, 9, (2102), (2017).
- Paolo D. A. Vignali, Joseph Barbi and Fan Pan, Metabolic Regulation of T Cell Immunity, Immune Metabolism in Health and Tumor, 10.1007/978-94-024-1170-6_2, (87-130), (2017).
- Sung Duk Jo, Gi-Hoon Nam, Gijung Kwak, Yoosoo Yang and Ick Chan Kwon, Harnessing designed nanoparticles: Current strategies and future perspectives in cancer immunotherapy, Nano Today, 10.1016/j.nantod.2017.10.008, (2017).
- Stavros Bashiardes, Timur Tuganbaev, Sara Federici and Eran Elinav, The microbiome in anti-cancer therapy, Seminars in Immunology, 10.1016/j.smim.2017.04.001, 32, (74-81), (2017).
- Si Yuan Sheng, Yong Gu, Chuan Gang Lu, Jian Yong Zou, Hai Hong and RongFu Wang, The distribution and function of human memory T cell subsets in lung cancer, Immunologic Research, 10.1007/s12026-016-8882-y, 65, 3, (639-650), (2017).
- James L. Riley and Luis J. Montaner, Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir, The Journal of Infectious Diseases, 215, suppl_3, (S160), (2017).
- Maurizio Zanetti, A second chance for telomerase reverse transcriptase in anticancer immunotherapy, Nature Reviews Clinical Oncology, 14, 2, (115), (2017).
- Nicholas M. Molino, Medea Neek, Jo Anne Tucker, Edward L. Nelson and Szu-Wen Wang, Viral-mimicking protein nanoparticle vaccine for eliciting anti-tumor responses, Biomaterials, 86, (83), (2016).
- Sarbari Ghosh, Madhurima Sarkar, Tithi Ghosh, Ipsita Guha, Avishek Bhuniya, Akata Saha, Shayani Dasgupta, Subhasis Barik, Anamika Bose and Rathindranath Baral, Neem leaf glycoprotein promotes dual generation of central and effector memory CD8 + T cells against sarcoma antigen vaccine to induce protective anti-tumor immunity, Molecular Immunology, 71, (42), (2016).
- Koki Fujimori, Toshiki Tezuka, Hiroyuki Ishiura, Jun Mitsui, Koichiro Doi, Jun Yoshimura, Hirobumi Tada, Takuya Matsumoto, Miho Isoda, Ryota Hashimoto, Nubutaka Hattori, Takuya Takahashi, Shinichi Morishita, Shoji Tsuji, Wado Akamatsu and Hideyuki Okano, Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines, Molecular Brain, 10.1186/s13041-016-0267-6, 9, 1, (2016).
- Felicity Stark, Michael McCluskie and Lakshmi Krishnan, Homologous Prime-Boost Vaccination with OVA Entrapped in Self-Adjuvanting Archaeosomes Induces High Numbers of OVA-Specific CD8+ T Cells that Protect Against Subcutaneous B16-OVA Melanoma, Vaccines, 4, 4, (44), (2016).
- Eli Gilboa, A quantum leap in cancer vaccines?, Journal for ImmunoTherapy of Cancer, 4, 1, (2016).
- Mutsunori Murahashi, Yasuki Hijikata, Kazunari Yamada, Yoshihiro Tanaka, Junji Kishimoto, Hiroyuki Inoue, Tomotoshi Marumoto, Atsushi Takahashi, Toshihiko Okazaki, Kazuyoshi Takeda, Masakazu Hirakawa, Hiroshi Fujii, Shinji Okano, Masaru Morita, Eishi Baba, Kazuhiro Mizumoto, Yoshihiko Maehara, Masao Tanaka, Koichi Akashi, Yoichi Nakanishi, Koji Yoshida, Takuya Tsunoda, Kazuo Tamura, Yusuke Nakamura and Kenzaburo Tani, Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors, Clinical Immunology, 166-167, (48), (2016).
- Petra Cerkovnik, Barbara Jezeršek Novaković, Vida Stegel and Srdjan Novaković, Changes in expression of genes involved in antitumor immunity in mice vaccinated with tumor vaccine composed of irradiated syngeneic tumor cells and CpG oligodeoxynucleotides, Molecular Immunology, 79, (1), (2016).
- Frederick S. Varn, Erik H. Andrews, David W. Mullins and Chao Cheng, Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles, Nature Communications, 7, (10248), (2016).
- Prince P. Pontes Leticia, M. F. Godinho Jr. Josemar, Moraes Elza, S. Arruda Diego, S. C. Almeida Caroline, C. Pinto Mayara, C. Costa Graciomar, N. M. Guerra Rosane, M. B. Torres Luce, F. Oliveira Vanessa, R. F. Nascimento Flávia and P. S. Azevedo-Santos Ana, Sensitization with babassu mesocarp induces activation of murine splenocytes against tumor cells, Journal of Medicinal Plants Research, 10, 34, (585), (2016).
- Duane Moogk, Shi Zhong, Zhiya Yu, Ivan Liadi, William Rittase, Victoria Fang, Janna Dougherty, Arianne Perez-Garcia, Iman Osman, Cheng Zhu, Navin Varadarajan, Nicholas P. Restifo, Alan B. Frey and Michelle Krogsgaard, Constitutive Lck Activity Drives Sensitivity Differences between CD8+Memory T Cell Subsets, The Journal of Immunology, 197, 2, (644), (2016).
- Victoria Klepsch, Natascha Hermann-Kleiter and Gottfried Baier, Beyond CTLA-4 and PD-1: Orphan nuclear receptor NR2F6 as T cell signaling switch and emerging target in cancer immunotherapy, Immunology Letters, 178, (31), (2016).
- MacLean Hall, Hao Liu, Mokenge Malafa, Barbara Centeno, Pamela J. Hodul, José Pimiento, Shari Pilon-Thomas and Amod A. Sarnaik, Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors, Journal for ImmunoTherapy of Cancer, 4, 1, (2016).
- Emanuele Trella, Nermin Raafat, Chantal Mengus, Emmanuel Traunecker, Valeria Governa, Swantje Heidtmann, Michael Heberer, Daniel Oertli, Giulio C. Spagnoli and Paul Zajac, CD40 ligand‐expressing recombinant vaccinia virus promotes the generation of CD8+ central memory T cells, European Journal of Immunology, 46, 2, (420-431), (2015).
- Pranay Dogra, Hazem E. Ghoneim, Hossam A. Abdelsamed and Ben Youngblood, Generating long‐lived CD8+ T‐cell memory: Insights from epigenetic programs, European Journal of Immunology, 46, 7, (1548-1562), (2016).
- Shin Kaneko, In Vitro Generation of Antigen-Specific T Cells from Induced Pluripotent Stem Cells of Antigen-Specific T Cell Origin, Tumor Immunology, 10.1007/978-1-4939-3338-9_6, (67-73), (2016).
- Anna Johansson, Juliana Hamzah and Ruth Ganss, More than a scaffold: Stromal modulation of tumor immunity, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 10.1016/j.bbcan.2015.06.001, 1865, 1, (3-13), (2016).
- C.G. Da Silva, Felix Rueda, C.W. Löwik, Ferry Ossendorp and Luis J. Cruz, Combinatorial prospects of nano-targeted chemoimmunotherapy, Biomaterials, 10.1016/j.biomaterials.2016.01.006, 83, (308-320), (2016).
- Zhao Li, Xiaobing Liu, Rongbin Guo and Pengfei Wang, CD4+Foxp3− type 1 regulatory T cells in glioblastoma multiforme suppress T cell responses through multiple pathways and are regulated by tumor-associated macrophages, The International Journal of Biochemistry & Cell Biology, 81, (1), (2016).
- Joseph A. Fraietta, Robert D. Schwab and Marcela V. Maus, Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells, Seminars in Oncology, 10.1053/j.seminoncol.2016.02.006, 43, 2, (291-299), (2016).
- John Reiser and Arnob Banerjee, Effector, Memory, and Dysfunctional CD8+T Cell Fates in the Antitumor Immune Response, Journal of Immunology Research, 2016, (1), (2016).
- Fumiyasu Momose, Naohiro Seo, Yasushi Akahori, Shin-ichi Sawada, Naozumi Harada, Toru Ogura, Kazunari Akiyoshi, Hiroshi Shiku and Costanza Emanueli, Guanine-Rich Sequences Are a Dominant Feature of Exosomal microRNAs across the Mammalian Species and Cell Types, PLOS ONE, 11, 4, (e0154134), (2016).
- Jeffrey C. Nolz, Molecular mechanisms of CD8+ T cell trafficking and localization, Cellular and Molecular Life Sciences, 72, 13, (2461), (2015).
- Yu Liu, Da-tong Zhang and Xin-guang Liu, mTOR Signaling in T Cell Immunity and Autoimmunity, International Reviews of Immunology, 10.3109/08830185.2014.933957, 34, 1, (50-66), (2014).
- Miki Ando, Toshinobu Nishimura, Satoshi Yamazaki, Tomoyuki Yamaguchi, Ai Kawana-Tachikawa, Tomonari Hayama, Yusuke Nakauchi, Jun Ando, Yasunori Ota, Satoshi Takahashi, Ken Nishimura, Manami Ohtaka, Mahito Nakanishi, John J. Miles, Scott R. Burrows, Malcolm K. Brenner and Hiromitsu Nakauchi, A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy, Stem Cell Reports, 5, 4, (597), (2015).
- Stephanie Du Four, Sarah K. Maenhout, Kari De Pierre, Dries Renmans, Simone P Niclou, Kris Thielemans, Bart Neyns and Joeri L Aerts, Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model, OncoImmunology, 4, 4, (e998107), (2015).
- Rahul Roychoudhuri, Francois Lefebvre, Mitsuo Honda, Li Pan, Yun Ji, Christopher A. Klebanoff, Carmen N. Nichols, Slim Fourati, Ahmed N. Hegazy, Jean-Philippe Goulet, Luca Gattinoni, Gary J. Nabel, Michel Gilliet, Mark Cameron, Nicholas P. Restifo, Rafick P. Sékaly and Lukas Flatz, Transcriptional profiles reveal a stepwise developmental program of memory CD8+ T cell differentiation, Vaccine, 33, 7, (914), (2015).
- Wei Ting Chang, Tzung Hsien Lai, Yau Jan Chyan, Shu Yi Yin, Yung Hsiang Chen, Wen Chi Wei, Ning-Sun Yang and Mauricio Martins Rodrigues, Specific Medicinal Plant Polysaccharides Effectively Enhance the Potency of a DC-Based Vaccine against Mouse Mammary Tumor Metastasis, PLOS ONE, 10, 3, (e0122374), (2015).
- Michelle H. Nelson, Marshall A. Diven, Logan W. Huff and Chrystal M. Paulos, Harnessing the Microbiome to Enhance Cancer Immunotherapy, Journal of Immunology Research, 2015, (1), (2015).
- Katherine Waugh, Sonia Leach and Jill Slansky, Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity, Vaccines, 3, 4, (771), (2015).
- Pawan Kumar, Vini John, Soumitra Marathe, Gobardhan Das and Sangeeta Bhaskar, Mycobacterium indicus pranii induces dendritic cell activation, survival, and Th1/Th17 polarization potential in a TLR‐dependent manner, Journal of Leukocyte Biology, 97, 3, (511-520), (2015).
- Rasha Abu Eid, Kevin M Friedman, Mikayel Mkrtichyan, Andrea Walens, William King, John Janik and Samir N Khleif, Akt1 and -2 inhibition diminishes terminal differentiation and enhances central memory CD8+T-cell proliferation and survival, OncoImmunology, 4, 5, (e1005448), (2015).
- Melissa N. McCracken, Dimitrios N. Vatakis, Dhaval Dixit, Jami McLaughlin, Jerome A. Zack and Owen N. Witte, Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging, Journal of Clinical Investigation, 10.1172/JCI77326, 125, 5, (1815-1826), (2015).
- Demissie Alemayehu, Eric Utt and Charles Knirsch, Vaccines: A review of immune‐based interventions to prevent and treat disease, The Journal of Clinical Pharmacology, 55, S3, (S93-S102), (2015).
- Cicely Macnamara and Raluca Eftimie, Memory versus effector immune responses in oncolytic virotherapies, Journal of Theoretical Biology, 377, (1), (2015).
- Rossella Di Trolio, Ester Simeone, Giuseppe Di Lorenzo, Carlo Buonerba and Paolo Antonio Ascierto, The use of interferon in melanoma patients: A systematic review, Cytokine & Growth Factor Reviews, 26, 2, (203), (2015).
- Oscar Okwudiri Onyema, Lore Decoster, Rose Njemini, Louis Nuvagah Forti, Ivan Bautmans, Marc De Waele and Tony Mets, Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control study, BMC Cancer, 15, 1, (2015).
- Rahul Roychoudhuri, Robert L Eil and Nicholas P Restifo, The interplay of effector and regulatory T cells in cancer, Current Opinion in Immunology, 33, (101), (2015).
- Drew C. Deniger, Jianqiang Yu, M. Helen Huls, Matthew J. Figliola, Tiejuan Mi, Sourindra N. Maiti, George F. Widhopf, Lenka V. Hurton, Radhika Thokala, Harjeet Singh, Simon Olivares, Richard E. Champlin, William G. Wierda, Thomas J. Kipps, Laurence J. N. Cooper and Derya Unutmaz, Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations, PLOS ONE, 10, 6, (e0128151), (2015).
- J. Feucht, K. Opherk, P. Lang, S. Kayser, L. Hartl, W. Bethge, S. Matthes-Martin, P. Bader, M. H. Albert, B. Maecker-Kolhoff, J. Greil, H. Einsele, P.-G. Schlegel, F. R. Schuster, B. Kremens, C. Rossig, B. Gruhn, R. Handgretinger and T. Feuchtinger, Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT, Blood, 125, 12, (1986), (2015).
- Asim Amin, Arkadiusz Z Dudek, Theodore F Logan, Raymond S Lance, Jeffrey M Holzbeierlein, Jennifer J Knox, Viraj A Master, Sumanta K Pal, Wilson H Miller, Lawrence I Karsh, Irina Y Tcherepanova, Mark A DeBenedette, W Lee Williams, Douglas C Plessinger, Charles A Nicolette and Robert A Figlin, Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results, Journal for ImmunoTherapy of Cancer, 3, 1, (2015).
- Qiang Zou, Jin Jin, Yichuan Xiao, Xiaofei Zhou, Hongbo Hu, Xuhong Cheng, Nasser Kazimi, Stephen E. Ullrich and Shao-Cong Sun, T Cell Intrinsic USP15 Deficiency Promotes Excessive IFN-γ Production and an Immunosuppressive Tumor Microenvironment in MCA-Induced Fibrosarcoma, Cell Reports, 13, 11, (2470), (2015).
- Patty Sachamitr, Simon Hackett and Paul Jonathan Fairchild, Induced Pluripotent Stem Cells: Challenges and Opportunities for Cancer Immunotherapy, Frontiers in Immunology, 5, (2014).
- Bangxing Hong, Haiyan Li, Yong Lu, Mingjun Zhang, Yuhuan Zheng, Jianfei Qian and Qing Yi, USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity, Molecular Cancer, 13, 1, (132), (2014).
- Chun-Hui Yuan, Xue-Qin Yang, Cheng-Liang Zhu, Shao-Ping Liu, Bi-Cheng Wang and Fu-Bing Wang, Interleukin-7 Enhances the in Vivo Anti-tumor Activity of Tumor-reactive CD8 + T cells with Induction of IFN-gamma in a Murine Breast Cancer Model , Asian Pacific Journal of Cancer Prevention, 10.7314/APJCP.2014.15.1.265, 15, 1, (265-271), (2014).
- C. M. O'Connor and H. Wilson-Robles, Developing T Cell Cancer Immunotherapy in the Dog with Lymphoma, ILAR Journal, 55, 1, (169), (2014).
- Donna L. Farber, Naomi A. Yudanin and Nicholas P. Restifo, Human memory T cells: generation, compartmentalization and homeostasis, Nature Reviews Immunology, 14, 1, (24), (2014).
- Anna Pasetto, Soo Aleman and Margaret Chen, Functional Attributes of Responding T Cells in HCV Infection: The Recent Advances in Engineering Functional Antiviral T Cells, Archivum Immunologiae et Therapiae Experimentalis, 62, 1, (23), (2014).
- Jacqueline K Flynn and Paul R Gorry, Stem memory T cells (TSCM)—their role in cancer and HIV immunotherapies, Clinical & Translational Immunology, 3, 7, (2014).
- Raquel Gomez-Eerland, Bastiaan Nuijen, Bianca Heemskerk, Nienke van Rooij, Joost H. van den Berg, Jos H. Beijnen, Wolfgang Uckert, Pia Kvistborg, Ton N. Schumacher, John B.A.G. Haanen and Annelies Jorritsma, Manufacture of Gene-Modified Human T-Cells with a Memory Stem/Central Memory Phenotype, Human Gene Therapy Methods, 25, 5, (277), (2014).
- N. P. Restifo, Big bang theory of stem-like T cells confirmed, Blood, 124, 4, (476), (2014).
- Hui Yang, Xianghui Wang, Yan Zhang, Huanrong Liu, Jiongbo Liao, Kun Shao, Yiwei Chu and Guangwei Liu, Modulation of TSC–mTOR Signaling on Immune Cells in Immunity and Autoimmunity, Journal of Cellular Physiology, 229, 1, (17-26), (2013).
- Joseph G. Crompton, Madhusudhanan Sukumar and Nicholas P. Restifo, Uncoupling T‐cell expansion from effector differentiation in cell‐based immunotherapy, Immunological Reviews, 257, 1, (264-276), (2013).
- Chava Perry and Aaron Polliack, Lenalidomide and T-cell homeostasis: tolerating immune reconstitution after autologous stem cell transplant, Leukemia & Lymphoma, 55, 8, (1699), (2014).
- V Chiarion-Sileni, J Pigozzo, P A Ascierto, E Simeone, M Maio, L Calabrò, P Marchetti, F De Galitiis, A Testori, P F Ferrucci, P Queirolo, F Spagnolo, P Quaglino, F Carnevale Schianca, M Mandalà, L Di Guardo and M Del Vecchio, Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy, British Journal of Cancer, 110, 7, (1721), (2014).
- Julia Scheiermann and Dennis M. Klinman, Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer, Vaccine, 32, 48, (6377), (2014).
- Joseph G. Crompton, David Clever, Raul Vizcardo, Mahendra Rao and Nicholas P. Restifo, Reprogramming antitumor immunity, Trends in Immunology, 35, 4, (178), (2014).
- Alexey Berezhnoy, Iris Castro, Agata Levay, Thomas R. Malek and Eli Gilboa, Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity, Journal of Clinical Investigation, 124, 1, (188), (2014).
- Alex Berezhnoy, Anugraha Rajagopalan and Eli Gilboa, A clinically useful approach to enhance immunological memory and antitumor immunity, OncoImmunology, 3, 5, (e28811), (2014).
- A. B. van der Waart, N. M. P. van de Weem, F. Maas, C. S. M. Kramer, M. G. D. Kester, J. H. F. Falkenburg, N. Schaap, J. H. Jansen, R. van der Voort, L. Gattinoni, W. Hobo and H. Dolstra, Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy, Blood, 124, 23, (3490), (2014).
- R. Zhang, F. Li, H. Li, J. Yu and X. Ren, The clinical significance of memory T cells and its subsets in gastric cancer, Clinical and Translational Oncology, 16, 3, (257), (2014).
- Cristina Falci, Ketty Gianesin, Giuseppe Sergi, Silvia Giunco, Irene De Ronch, Sara Valpione, Caterina Soldà, Pasquale Fiduccia, Sara Lonardi, Marisa Zanchetta, Sonia Keppel, Antonella Brunello, Valeria Zafferri, Enzo Manzato, Anita De Rossi and Vittorina Zagonel, Immune senescence and cancer in elderly patients: Results from an exploratory study, Experimental Gerontology, 10.1016/j.exger.2013.09.011, 48, 12, (1436-1442), (2013).
- Madhusudhanan Sukumar, Jie Liu, Yun Ji, Murugan Subramanian, Joseph G. Crompton, Zhiya Yu, Rahul Roychoudhuri, Douglas C. Palmer, Pawel Muranski, Edward D. Karoly, Robert P. Mohney, Christopher A. Klebanoff, Ashish Lal, Toren Finkel, Nicholas P. Restifo and Luca Gattinoni, Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function, Journal of Clinical Investigation, 10.1172/JCI69589, 123, 10, (4479-4488), (2013).
- D Reyes, L Salazar, E Espinoza, C Pereda, E Castellón, R Valdevenito, C Huidobro, M Inés Becker, A Lladser, M N López and F Salazar-Onfray, Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients, British Journal of Cancer, 109, 6, (1488), (2013).
- Barbara A. Fox, Kiah L. Sanders, Shan Chen and David J. Bzik, Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines, Trends in Parasitology, 29, 9, (431), (2013).
- Toshinobu Nishimura, Shin Kaneko, Ai Kawana-Tachikawa, Yoko Tajima, Haruo Goto, Dayong Zhu, Kaori Nakayama-Hosoya, Shoichi Iriguchi, Yasushi Uemura, Takafumi Shimizu, Naoya Takayama, Daisuke Yamada, Ken Nishimura, Manami Ohtaka, Nobukazu Watanabe, Satoshi Takahashi, Aikichi Iwamoto, Haruhiko Koseki, Mahito Nakanishi, Koji Eto and Hiromitsu Nakauchi, Generation of Rejuvenated Antigen-Specific T Cells by Reprogramming to Pluripotency and Redifferentiation, Cell Stem Cell, 12, 1, (114), (2013).
- Joseph G. Crompton, Mahendra Rao and Nicholas P. Restifo, Memoirs of a Reincarnated T Cell, Cell Stem Cell, 12, 1, (6), (2013).
- Alessia Ricupito, Matteo Grioni, Arianna Calcinotto and Matteo Bellone, Boosting anticancer vaccines, OncoImmunology, 2, 7, (e25032), (2013).
- Christian Perez-Shibayama, Cristina Gil-Cruz, Monika Nussbacher, Eva Allgäuer, Luisa Cervantes-Barragan, Roland Züst, Burkhard Ludewig and Ramon Arens, Dendritic Cell-Specific Delivery of Flt3L by Coronavirus Vectors Secures Induction of Therapeutic Antitumor Immunity, PLoS ONE, 8, 11, (e81442), (2013).
- L Chen, J L Taylor, N C Sabins, D B Lowe, Y Qu, Z You and W J Storkus, Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cells, Cancer Gene Therapy, 10.1038/cgt.2013.42, 20, 8, (469-477), (2013).
- Arnaud Scherpereel, Bogdan Dragos Grigoriu, Marc Noppen, Thomas Gey, Bachar Chahine, Simon Baldacci, Jacques Trauet, Marie-Christine Copin, Jean-Paul Dessaint, Henri Porte and Myriam Labalette, Defect in recruiting effector memory CD8+T-cells in malignant pleural effusions compared to normal pleural fluid, BMC Cancer, 10.1186/1471-2407-13-324, 13, 1, (2013).
- Koichi Araki and Rafi Ahmed, AMPK: A metabolic switch for CD8+ T‐cell memory, European Journal of Immunology, 43, 4, (878-881), (2013).
- Abdul M. Mondal, Izumi Horikawa, Sharon R. Pine, Kaori Fujita, Katherine M. Morgan, Elsa Vera, Sharlyn J. Mazur, Ettore Appella, Borivoj Vojtesek, Maria A. Blasco, David P. Lane and Curtis C. Harris, p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes, Journal of Clinical Investigation, 123, 12, (5247), (2013).
- P C Schuberth, G Jakka, S M Jensen, A Wadle, F Gautschi, D Haley, S Haile, A Mischo, G Held, M Thiel, M Tinguely, C B Bifulco, B A Fox, C Renner and U Petrausch, Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma, Gene Therapy, 10.1038/gt.2012.48, 20, 4, (386-395), (2012).
- Channakeshava Sokke Umeshappa, Yufeng Xie, Shulin Xu, Roopa Hebbandi Nanjundappa, Andrew Freywald, Yulin Deng, Hong Ma, Jim Xiang and Marek Cebecauer, Th Cells Promote CTL Survival and Memory via Acquired pMHC-I and Endogenous IL-2 and CD40L Signaling and by Modulating Apoptosis-Controlling Pathways, PLoS ONE, 8, 6, (e64787), (2013).
- Nicholas P Restifo and Luca Gattinoni, Lineage relationship of effector and memory T cells, Current Opinion in Immunology, 25, 5, (556), (2013).
- Lingbing Zhang, Dongdong Feng, Lynda X. Yu, Kangla Tsung and Jeffrey A. Norton, Preexisting antitumor immunity augments the antitumor effects of chemotherapy, Cancer Immunology, Immunotherapy, 62, 6, (1061), (2013).
- P. Muranski and N. P. Restifo, Essentials of Th17 cell commitment and plasticity, Blood, 10.1182/blood-2012-09-378653, 121, 13, (2402-2414), (2013).
- Friedhelm R. Schuster, Roland Meisel, Monika Führer, Susanne Reuther, Julia Hauer, Johanna Tischer, Tobias Feuchtinger, Hans-Jürgen Laws, Hans-Jochem Kolb and Arndt Borkhardt, Anti-leukaemic activity of a novel haploidentical-transplantation approach employing unmanipulated bone marrow followed by CD6-depleted peripheral blood stem cells in children with refractory/relapsed acute leukaemia, British Journal of Haematology, 162, 6, (802), (2013).
- Drew C Deniger, Kirsten Switzer, Tiejuan Mi, Sourindra Maiti, Lenka Hurton, Harjeet Singh, Helen Huls, Simon Olivares, Dean A Lee, Richard E Champlin and Laurence JN Cooper, Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor, Molecular Therapy, 21, 3, (638), (2013).
- Shicheng Yang, Gary E. Archer, Catherine E. Flores, Duane A. Mitchell and John H. Sampson, A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model, Cancer Immunology, Immunotherapy, 62, 11, (1649), (2013).
- Dimitrios N Vatakis, Balamurugan Arumugam, Sohn G Kim, Gregory Bristol, Otto Yang and Jerome A Zack, Introduction of Exogenous T-cell Receptors Into Human Hematopoietic Progenitors Results in Exclusion of Endogenous T-cell Receptor Expression, Molecular Therapy, 21, 5, (1055), (2013).
- D. Abate-Daga, K.-i. Hanada, J. L. Davis, J. C. Yang, S. A. Rosenberg and R. A. Morgan, Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes, Blood, 122, 8, (1399), (2013).
- Vivian L. Weiss, Timothy H. Lee, Hong Song, Theodore S. Kouo, Chelsea M. Black, George Sgouros, Elizabeth M. Jaffee, Todd D. Armstrong and George Kassiotis, Trafficking of High Avidity HER-2/neu-Specific T Cells into HER-2/neu-Expressing Tumors after Depletion of Effector/Memory-Like Regulatory T Cells, PLoS ONE, 7, 2, (e31962), (2012).
- Nicholas P. Restifo, Mark E. Dudley and Steven A. Rosenberg, Adoptive immunotherapy for cancer: harnessing the T cell response, Nature Reviews Immunology, 12, 4, (269), (2012).
- J. Banchereau, L. Thompson-Snipes, S. Zurawski, J.-P. Blanck, Y. Cao, S. Clayton, J.-P. Gorvel, G. Zurawski and E. Klechevsky, The differential production of cytokines by human Langerhans cells and dermal CD14+ DCs controls CTL priming, Blood, 119, 24, (5742), (2012).
- Sylvia Lee and Kim Margolin, Tumor-Infiltrating Lymphocytes in Melanoma, Current Oncology Reports, 14, 5, (468), (2012).
- David Avigan, Jacalyn Rosenblatt and Donald Kufe, Dendritic/Tumor Fusion Cells as Cancer Vaccines, Seminars in Oncology, 39, 3, (287), (2012).
- Heriberto Prado-Garcia, Susana Romero-Garcia, Dolores Aguilar-Cazares, Manuel Meneses-Flores and Jose Sullivan Lopez-Gonzalez, Tumor-Induced CD8+ T-Cell Dysfunction in Lung Cancer Patients, Clinical and Developmental Immunology, 10.1155/2012/741741, 2012, (1-11), (2012).
- Petra Baumgaertner, Camilla Jandus, Jean-Paul Rivals, Laurent Derré, Tanja Lövgren, Lukas Baitsch, Philippe Guillaume, Immanuel F. Luescher, Gregoire Berthod, Maurice Matter, Nathalie Rufer, Olivier Michielin and Daniel E. Speiser, Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells, International Journal of Cancer, 130, 11, (2607), (2012).
- Thomas Blankenstein, Pierre G. Coulie, Eli Gilboa and Elizabeth M. Jaffee, The determinants of tumour immunogenicity, Nature Reviews Cancer, 12, 4, (307), (2012).
- Mathilde Allard, Pierre Tonnerre, Steven Nedellec, Romain Oger, Alexis Morice, Yannick Guilloux, Elisabeth Houssaint, Béatrice Charreau, Nadine Gervois and Vassiliki A. Boussiotis, HLA-E-Restricted Cross-Recognition of Allogeneic Endothelial Cells by CMV-Associated CD8 T Cells: A Potential Risk Factor following Transplantation, PLoS ONE, 7, 11, (e50951), (2012).
- Y Hashii, E Sato-Miyashita, R Matsumura, S Kusuki, H Yoshida, H Ohta, N Hosen, A Tsuboi, Y Oji, Y Oka, H Sugiyama and K Ozono, WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission, Leukemia, 26, 3, (530), (2012).
- Andrew D. Kaiser, Kerstin Schuster, Jules Gadiot, Lisa Borkner, Henry Daebritz, Clemens Schmitt, Reinhard Andreesen and Christian Blank, Reduced tumor‐antigen density leads to PD‐1/PD‐L1‐mediated impairment of partially exhausted CD8+ T cells, European Journal of Immunology, 42, 3, (662-671), (2012).
- Felicity C. Stark, Komal Gurnani, Subash Sad, Lakshmi Krishnan and Ryan M. Teague, Lack of Functional Selectin Ligand Interactions Compromises Long Term Tumor Protection by CD8+ T Cells, PLoS ONE, 7, 2, (e32211), (2012).
- Wei Hu, Rui-Rui Zheng, Hui-Xia Cui, Dan Yue, Yong Wang and You-Hong Jiang, Effects of bortezomib in sensitizing human prostate cancer cell lines to NK-mediated cytotoxicity, Asian Journal of Andrology, 14, 5, (695), (2012).
- Hua Liu, Three-Dimensional Tumor Model and T-Lymphocytes Immunotherapy for Cancer, Recent Advances in Cancer Research and Therapy, 10.1016/B978-0-12-397833-2.00011-X, (245-286), (2012).
- Warren L. Denning, Jun Xu, Siqi Guo, Christopher A. Klug, Zdenek Hel and Xia Jin, Limited Transplantation of Antigen-Expressing Hematopoietic Stem Cells Induces Long-Lasting Cytotoxic T Cell Responses, PLoS ONE, 6, 2, (e16897), (2011).
- R. Q. Le, J. J. Melenhorst, M. Battiwalla, B. Hill, S. Memon, B. N. Savani, A. Shenoy, N. F. Hensel, E. K. Koklanaris, K. Keyvanfar, F. T. Hakim, D. C. Douek and A. J. Barrett, Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation, Blood, 117, 19, (5250), (2011).
- Koichi Araki, Ali H Ellebedy and Rafi Ahmed, TOR in the immune system, Current Opinion in Cell Biology, 23, 6, (707), (2011).
- Yongjun Jo, Soo Hwa Kim, Kwangsang Koh, Jongmoon Park, Yang Bo Shim, Jihyang Lim, Yonggoo Kim, Yeon-Joon Park and Kyungja Han, Reliable, Accurate Determination of the Leukocyte Differential of Leukopenic Samples by Using Hematoflow Method, The Korean Journal of Laboratory Medicine, 10.3343/kjlm.2011.31.3.131, 31, 3, (131), (2011).
- Jana Albrecht, Michaela Frey, Daniel Teschner, Alexander Carbol, Matthias Theobald, Wolfgang Herr and Eva Distler, IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype, Cancer Immunology, Immunotherapy, 60, 2, (235), (2011).
- Keli L. Hippen, James L. Riley, Carl H. June and Bruce R. Blazar, Clinical perspectives for regulatory T cells in transplantation tolerance, Seminars in Immunology, 23, 6, (462), (2011).
- Mohamed Labib Salem, Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses, Immunology Letters, 137, 1-2, (9), (2011).
- Mariagrazia Michieli, Mario Mazzucato, Umberto Tirelli and Paolo De Paoli, Stem Cell Transplantation for Lymphoma Patients with HIV Infection, Cell Transplantation, 20, 3, (351), (2011).
- Pawel Muranski, Zachary A. Borman, Sid P. Kerkar, Christopher A. Klebanoff, Yun Ji, Luis Sanchez-Perez, Madhusudhanan Sukumar, Robert N. Reger, Zhiya Yu, Steven J. Kern, Rahul Roychoudhuri, Gabriela A. Ferreyra, Wei Shen, Scott K. Durum, Lionel Feigenbaum, Douglas C. Palmer, Paul A. Antony, Chi-Chao Chan, Arian Laurence, Robert L. Danner, Luca Gattinoni and Nicholas P. Restifo, Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature, Immunity, 10.1016/j.immuni.2011.09.019, 35, 6, (972-985), (2011).
- K. L. Hippen, S. C. Merkel, D. K. Schirm, C. M. Sieben, D. Sumstad, D. M. Kadidlo, D. H. McKenna, J. S. Bromberg, B. L. Levine, J. L. Riley, C. H. June, P. Scheinberg, D. C. Douek, J. S. Miller, J. E. Wagner and B. R. Blazar, Massive ex Vivo Expansion of Human Natural Regulatory T Cells (Tregs) with Minimal Loss of in Vivo Functional Activity, Science Translational Medicine, 3, 83, (83ra41), (2011).
- Alison M. McDonnell, Anna K. Nowak and Richard A. Lake, Contribution of the immune system to the chemotherapeutic response, Seminars in Immunopathology, 33, 4, (353), (2011).
- Katelyn T. Byrne, Anik L. Côté, Peisheng Zhang, Shannon M. Steinberg, Yanxia Guo, Rameeza Allie, Weijun Zhang, Marc S. Ernstoff, Edward J. Usherwood and Mary Jo Turk, Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma, Journal of Clinical Investigation, 121, 5, (1797), (2011).
- D. N. Vatakis, R. C. Koya, C. C. Nixon, L. Wei, S. G. Kim, P. Avancena, G. Bristol, D. Baltimore, D. B. Kohn, A. Ribas, C. G. Radu, Z. Galic and J. A. Zack, Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells, Proceedings of the National Academy of Sciences, 108, 51, (E1408), (2011).
- Shigeo Koido, Sadamu Homma, Akitaka Takahara, Yoshihisa Namiki, Hideo Komita, Eijiro Nagasaki, Masaki Ito, Keisuke Nagatsuma, Kan Uchiyama, Kenichi Satoh, Toshifumi Ohkusa, Jianlin Gong and Hisao Tajiri, Immunologic Monitoring of Cellular Responses by Dendritic/Tumor Cell Fusion Vaccines, Journal of Biomedicine and Biotechnology, 2011, (1), (2011).
- Christopher A. Klebanoff, Nicolas Acquavella, Zhiya Yu and Nicholas P. Restifo, Therapeutic cancer vaccines: are we there yet?, Immunological Reviews, 239, 1, (27-44), (2010).
- Jarrod P. Holmes, Guy T. Clifton, Ritesh Patil, Linda C. Benavides, Jeremy D. Gates, Alexander Stojadinovic, Elizabeth A. Mittendorf, Sathibalan Ponniah and George E. Peoples, Use of booster inoculations to sustain the clinical effect of an adjuvant breast cancer vaccine, Cancer, 117, 3, (463-471), (2010).
- Maria R Parkhurst, James C Yang, Russell C Langan, Mark E Dudley, Debbie-Ann N Nathan, Steven A Feldman, Jeremy L Davis, Richard A Morgan, Maria J Merino, Richard M Sherry, Marybeth S Hughes, Udai S Kammula, Giao Q Phan, Ramona M Lim, Stephen A Wank, Nicholas P Restifo, Paul F Robbins, Carolyn M Laurencot and Steven A Rosenberg, T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis, Molecular Therapy, 19, 3, (620), (2011).
- Omar A. Ali, Edward Doherty, David J. Mooney and Dwaine Emerich, Relationship of vaccine efficacy to the kinetics of DC and T-cell responses induced by PLG-based cancer vaccines, Biomatter, 1, 1, (66), (2011).
- Yun Ji, Zoltan Pos, Mahadev Rao, Christopher A Klebanoff, Zhiya Yu, Madhusudhanan Sukumar, Robert N Reger, Douglas C Palmer, Zachary A Borman, Pawel Muranski, Ena Wang, David S Schrump, Francesco M Marincola, Nicholas P Restifo and Luca Gattinoni, Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells, Nature Immunology, 12, 12, (1230), (2011).
- Ranran Zhang and Thomas P. Loughran, Off-target effects of tyrosine kinase inhibitors: Beauty or the Beast?, Leukemia & Lymphoma, 52, 4, (556), (2011).
- Yann Godet, Juliette Desfrançois, Virginie Vignard, Dirk Schadendorf, Amir Khammari, Brigitte Dreno, Francine Jotereau and Nathalie Labarrière, Frequent occurrence of high affinity T cells against MELOE‐1 makes this antigen an attractive target for melanoma immunotherapy, European Journal of Immunology, 40, 6, (1786-1794), (2010).
- Anja Liepert, Christine Grabrucker, Andreas Kremser, Julia Dreyßig, Christian Ansprenger, Markus Freudenreich, Tanja Kroell, Roland Reibke, Johanna Tischer, Cornelia Schweiger, Christoph Schmid, Hans-Jochem Kolb and Helga Schmetzer, Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential, Cellular Immunology, 265, 1, (23), (2010).
- I-Hsuan Chen, Yuen-Liang Lai, Chien-Liang Wu, Yi-Fang Chang, Chen-Chung Chu, I-Fang Tsai, Fang-Ju Sun and Yen-Ta Lu, Immune impairment in patients with terminal cancers: influence of cancer treatments and cytomegalovirus infection, Cancer Immunology, Immunotherapy, 59, 2, (323), (2010).
- Mohamed Labib Salem and David J. Cole, Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination, Cancer Immunology, Immunotherapy, 59, 3, (341), (2010).
- P Neeson, A Shin, K M Tainton, P Guru, H M Prince, S J Harrison, S Peinert, M J Smyth, J A Trapani, M H Kershaw, P K Darcy and D S Ritchie, Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype, Gene Therapy, 17, 9, (1105), (2010).
- Hui Zhang and Gary G. Meadows, Chronic alcohol consumption enhances myeloid-derived suppressor cells in B16BL6 melanoma-bearing mice, Cancer Immunology, Immunotherapy, 59, 8, (1151), (2010).
- Pouneh Dokouhaki, Mei Han, Betty Joe, Ming Li, Michael R. Johnston, Ming-Sound Tsao and Li Zhang, Adoptive immunotherapy of cancer using ex vivo expanded human γδ T cells: A new approach, Cancer Letters, 297, 1, (126), (2010).
- Rédouane Rouas, Haidar Akl, Hussein Fayyad-Kazan, Nabil El Zein, Bassam Badran, Bérangère Nowak, Hugues Duvillier, Philippe Martiat and Philippe Lewalle, Dendritic Cells Generated in Clinical Grade Bags Strongly Differ in Immune Functionality When Compared With Classical DCs Generated in Plates, Journal of Immunotherapy, 33, 4, (352), (2010).
- Koichi Araki, Ben Youngblood and Rafi Ahmed, The role of mTOR in memory CD8+ T‐cell differentiation, Immunological Reviews, 235, 1, (234-243), (2010).
- Ayako Murao, Yoshihiro Oka, Akihiro Tsuboi, Olga A. Elisseeva, Yukie Tanaka‐Harada, Fumihiro Fujiki, Hiroko Nakajima, Sumiyuki Nishida, Naoki Hosen, Toshiaki Shirakata, Nobuyuki Hashimoto, Akira Myoui, Takafumi Ueda, Yoshito Takeda, Tadashi Osaki, Takayuki Enomoto, Hideki Yoshikawa, Tadashi Kimura, Yusuke Oji, Ichiro Kawase and Haruo Sugiyama, High frequencies of less differentiated and more proliferative WT1‐specific CD8+ T cells in bone marrow in tumor‐bearing patients: An important role of bone marrow as a secondary lymphoid organ, Cancer Science, 101, 4, (848-854), (2009).
- Paul C. Tumeh, Richard C. Koya, Thinle Chodon, Nicholas A. Graham, Thomas G. Graeber, Begoña Comin-Anduix and Antoni Ribas, The Impact of Ex Vivo Clinical Grade Activation Protocols on Human T-cell Phenotype and Function for the Generation of Genetically Modified Cells for Adoptive Cell Transfer Therapy, Journal of Immunotherapy, 10.1097/CJI.0b013e3181f1d644, 33, 8, (759-768), (2010).
- Protul A. Shrikant, Rajesh Rao, Qingsheng Li, Joshua Kesterson, Cheryl Eppolito, Axel Mischo and Pankaj Singhal, Regulating functional cell fates in CD8 T cells, Immunologic Research, 46, 1-3, (12), (2010).
- Gloria H. Y. Lin, Yuanqing Liu, Thanuja Ambagala, Byoung S. Kwon, Pamela S. Ohashi, Tania H. Watts and Mario A. Ostrowski, Evaluating the Cellular Targets of Anti-4-1BB Agonist Antibody during Immunotherapy of a Pre-Established Tumor in Mice, PLoS ONE, 5, 6, (e11003), (2010).
- Maria R. Sorensen, Peter J. Holst, Maria A. Steffensen, Jan P. Christensen and Allan R. Thomsen, Adenoviral vaccination combined with CD40 stimulation and CTLA-4 blockage can lead to complete tumor regression in a murine melanoma model, Vaccine, 10.1016/j.vaccine.2010.07.066, 28, 41, (6757-6764), (2010).
- Yolanda Nesbeth and Jose R. Conejo-Garcia, Harnessing the Effect of Adoptively Transferred Tumor-Reactive T Cells on Endogenous (Host-Derived) Antitumor Immunity, Clinical and Developmental Immunology, 10.1155/2010/139304, 2010, (1-11), (2010).
- R. C. Koya, S. Mok, B. Comin-Anduix, T. Chodon, C. G. Radu, M. I. Nishimura, O. N. Witte and A. Ribas, Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses, Proceedings of the National Academy of Sciences, 107, 32, (14286), (2010).
- G. Orive, O.A. Ali, E. Anitua, J.L. Pedraz and D.F. Emerich, Biomaterial-based technologies for brain anti-cancer therapeutics and imaging, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1806, 1, (96), (2010).
- Samuel Salot, Sylvain Bercegeay, Brigitte Dreno, Soraya Saïagh, Virginie Scaglione, Cécile Bonnafous and Hélène Sicard, Large scale expansion of Vγ9Vδ2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS “TCR γ/δ + T cell isolation kit”, Journal of Immunological Methods, 347, 1-2, (12), (2009).
- C. A. Klebanoff, Z. Yu, L. N. Hwang, D. C. Palmer, L. Gattinoni and N. P. Restifo, Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccination, Blood, 114, 9, (1776), (2009).
- O. A. Ali, D. Emerich, G. Dranoff and D. J. Mooney, In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in Mice, Science Translational Medicine, 1, 8, (8ra19), (2009).
- H. Navabi, B. Jasani, A. Reece, A. Clayton, Z. Tabi, C. Donninger, M. Mason and M. Adams, A clinical grade poly I:C-analogue (Ampligen®) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro, Vaccine, 27, 1, (107), (2009).
- Henrik Kloverpris, Ingrid Karlsson, Jesper Bonde, Mette Thorn, Lasse Vinner, Anders E Pedersen, Julie L Hentze, Betina S Andresen, Inge M Svane, Jan Gerstoft, Gitte Kronborg and Anders Fomsgaard, Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes, AIDS, 23, 11, (1329), (2009).
- Camilla Jandus, Daniel Speiser and Pedro Romero, Recent advances and hurdles in melanoma immunotherapy, Pigment Cell & Melanoma Research, 22, 6, (711-723), (2009).
- Luca Gattinoni, Xiao-Song Zhong, Douglas C Palmer, Yun Ji, Christian S Hinrichs, Zhiya Yu, Claudia Wrzesinski, Andrea Boni, Lydie Cassard, Lindsay M Garvin, Chrystal M Paulos, Pawel Muranski and Nicholas P Restifo, Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells, Nature Medicine, 15, 7, (808), (2009).
- Juliet C. Gray and Janice A. Kohler, Immunotherapy for neuroblastoma: Turning promise into reality, Pediatric Blood & Cancer, 53, 6, (931-940), (2009).
- Shikhar Mehrotra, Dimitrios Mougiakakos, C. Christian Johansson, Christina Voelkel‐Johnson and Rolf Kiessling, Chapter 6 Oxidative Stress and Lymphocyte Persistence, , 10.1016/S0065-230X(09)02006-5, (197-227), (2009).
- Michel M. Van den Heuvel, Sjaak A. Burgers and Nico van Zandwijk, Immunotherapy in Non–Small-Cell Lung Carcinoma: From Inflammation to Vaccination, Clinical Lung Cancer, 10, 2, (99), (2009).
- Daniel Hollyman, Jolanta Stefanski, Mark Przybylowski, Shirley Bartido, Oriana Borquez-Ojeda, Clare Taylor, Raymond Yeh, Vanessa Capacio, Malgorzata Olszewska, James Hosey, Michel Sadelain, Renier J. Brentjens and Isabelle Rivière, Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy, Journal of Immunotherapy, 32, 2, (169), (2009).
- Juliette Desfrançois, Laurent Derré, Murielle Corvaisier, Bernard Le Mével, Véronique Catros, Francine Jotereau and Nadine Gervois, Increased frequency of nonconventional double positive CD4CD8 αβ T cells in human breast pleural effusions, International Journal of Cancer, 125, 2, (374-380), (2009).
- Tae Heung Kang, Hyun Cheol Bae, Seok‐Ho Kim, Su Hong Seo, Sang Wook Son, Eun Young Choi, Seung‐Yong Seong and Tae Woo Kim, Modification of dendritic cells with interferon‐γ‐inducible protein‐10 gene to enhance vaccine potency, The Journal of Gene Medicine, 11, 10, (889-898), (2009).
- Karin Enell Smith, Sara Fritzell, Wiaam Badn, Sofia Eberstål, Shorena Janelidze, Edward Visse, Anna Darabi and Peter Siesjö, Cure of established GL261 mouse gliomas after combined immunotherapy with GM‐CSF and IFNγ is mediated by both CD8+ and CD4+ T‐cells, International Journal of Cancer, 124, 3, (630-637), (2008).
- Yuri Souwer, Martine E. D. Chamuleau, Arjan A. van de Loosdrecht, Eva Tolosa, Tineke Jorritsma, Jettie J. F. Muris, Marion J. Dinnissen-van Poppel, Sander N. Snel, Lisette van de Corput, Gert J. Ossenkoppele, Chris J. L. M. Meijer, Jacques J. Neefjes and S. Marieke van Ham, Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifiesHLA-DOAmRNA as a prognostic factor for survival, British Journal of Haematology, 145, 3, (334), (2009).
- Koichi Araki, Alexandra P. Turner, Virginia Oliva Shaffer, Shivaprakash Gangappa, Susanne A. Keller, Martin F. Bachmann, Christian P. Larsen and Rafi Ahmed, mTOR regulates memory CD8 T-cell differentiation, Nature, 460, 7251, (108), (2009).
- Shrimati Datta and Nora Sarvetnick, Lymphocyte proliferation in immune-mediated diseases, Trends in Immunology, 30, 9, (430), (2009).
- Stefan Peinert, Michael H Kershaw and H Miles Prince, Chimeric T cells for adoptive immunotherapy of cancer: using what have we learned to plan for the future, Immunotherapy, 1, 6, (905), (2009).
- L. Gattinoni, C. A. Klebanoff and N. P. Restifo, Pharmacologic Induction of CD8+ T Cell Memory: Better Living Through Chemistry, Science Translational Medicine, 1, 11, (11ps12), (2009).
- J. G. Casado, O. DelaRosa, G. Pawelec, E. Peralbo, E. Duran, F. Barahona, R. Solana and R. Tarazona, Correlation of effector function with phenotype and cell division after in vitro differentiation of naive MART-1-specific CD8+ T cells, International Immunology, 21, 1, (53), (2009).
- Rachel L. Rutishauser, Gislâine A. Martins, Sergey Kalachikov, Anmol Chandele, Ian A. Parish, Eric Meffre, Joshy Jacob, Kathryn Calame and Susan M. Kaech, Transcriptional Repressor Blimp-1 Promotes CD8+ T Cell Terminal Differentiation and Represses the Acquisition of Central Memory T Cell Properties, Immunity, 31, 2, (296), (2009).
- Katja Mueller, Oliver Schweier and Hanspeter Pircher, Efficacy of IL‐2‐ versus IL‐15‐stimulated CD8 T cells in adoptive immunotherapy, European Journal of Immunology, 38, 10, (2874-2885), (2008).
- Andrew Gray, Adam B. Raff, Maurizio Chiriva‐Internati, Si‐Yi Chen and W. Martin Kast, A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting, Immunological Reviews, 222, 1, (316-327), (2008).
- Chih-Sheng Chiang, Nathalie Kertesz and Zheng Liu, Diagnostic Approaches for Selecting Patient-Customized Therapies, Obviating Tumor Variability to Maximize Therapeutic Effect, Cancer Vaccines: Challenges and Opportunities in Translation, 10.3109/9781420054682.009, (181-204), (2010).
- Padmanee Sharma, Dean F. Bajorin, Achim A. Jungbluth, Harry Herr, Lloyd J. Old and Sacha Gnjatic, Immune Responses Detected in Urothelial Carcinoma Patients After Vaccination With NY-ESO-1 Protein Plus BCG and GM-CSF, Journal of Immunotherapy, 31, 9, (849), (2008).
- B. G. Till, M. C. Jensen, J. Wang, E. Y. Chen, B. L. Wood, H. A. Greisman, X. Qian, S. E. James, A. Raubitschek, S. J. Forman, A. K. Gopal, J. M. Pagel, C. G. Lindgren, P. D. Greenberg, S. R. Riddell and O. W. Press, Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells, Blood, 112, 6, (2261), (2008).
- Lakshmi Krishnan and G. Dennis Sprott, Archaeosome adjuvants: Immunological capabilities and mechanism(s) of action, Vaccine, 26, 17, (2043), (2008).
- A. Boni, P. Muranski, L. Cassard, C. Wrzesinski, C. M. Paulos, D. C. Palmer, L. Gattinoni, C. S. Hinrichs, C.-C. Chan, S. A. Rosenberg and N. P. Restifo, Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers, Blood, 112, 12, (4746), (2008).
- Shereen Amria, Christine Cameron, Robert Stuart and Azizul Haque, Defects in HLA class II antigen presentation in B-cell lymphomas, Leukemia & Lymphoma, 49, 2, (353), (2008).
- Kresten Skak, Michael Kragh, Diana Hausman, Mark J. Smyth and Pallavur V. Sivakumar, Interleukin 21: combination strategies for cancer therapy, Nature Reviews Drug Discovery, 7, 3, (231), (2008).
- Xian-Hui He, Qian-Tao Jia, Feng-Yao Li, Mark Saltis, Yi Liu, Li-Hui Xu and Qing-Bing Zha, CD8+ T cells specific for both persistent and non-persistent viruses display distinct differentiation phenotypes but have similar level of PD-1 expression in healthy Chinese individuals, Clinical Immunology, 126, 2, (222), (2008).
- R. Zhang, M. V. Shah, J. Yang, S. B. Nyland, X. Liu, J. K. Yun, R. Albert and T. P. Loughran, Network model of survival signaling in large granular lymphocyte leukemia, Proceedings of the National Academy of Sciences, 105, 42, (16308), (2008).
- G. Alexandre‐Pires, M.C. Algueró, L. Mendes‐Jorge, H. Trindade, M. Correia and J.A. Esperança Pina, Immunophenotyping of lymphocyte subsets in the third eyelid tissue in dogs (Canis familiaris): Morphological, microvascular, and secretory aspects of this ocular adnexa, Microscopy Research and Technique, 71, 7, (521), (2008).
- Seung-Tae Lee, Shujuan Liu, Laszlo Radvanyi, Pariya Sukhumalchandra, Jeffrey J. Molldrem, Eric D. Wieder, Patrick Hwu, Yong-Jun Liu, Larry W. Kwak, Gregory Lizée and Sattva S. Neelapu, A novel strategy for rapid and efficient isolation of human tumor-specific CD4+ and CD8+ T-cell clones, Journal of Immunological Methods, 331, 1-2, (13), (2008).
- Angel Varela-Rohena, Carmine Carpenito, Elena E. Perez, Max Richardson, Richard V. Parry, Michael Milone, John Scholler, Xueli Hao, Angela Mexas, Richard G. Carroll, Carl H. June and James L. Riley, Genetic engineering of T cells for adoptive immunotherapy, Immunologic Research, 42, 1-3, (166), (2008).
- Claude Sportès, Frances T. Hakim, Sarfraz A. Memon, Hua Zhang, Kevin S. Chua, Margaret R. Brown, Thomas A. Fleisher, Michael C. Krumlauf, Rebecca R. Babb, Catherine K. Chow, Terry J. Fry, Julie Engels, Renaud Buffet, Michel Morre, Robert J. Amato, David J. Venzon, Robert Korngold, Andrew Pecora, Ronald E. Gress and Crystal L. Mackall, Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets, The Journal of Experimental Medicine, 205, 7, (1701), (2008).
- Inge Marie Svane, Anders E. Pedersen, Kirsten Nikolajsen and Mai-Britt Zocca, Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2, Vaccine, 26, 36, (4716), (2008).
- A.C. Hobeika, T. Osada, D. Serra, S. Peplinski, K. Hanson, Y. Tanaka, D. Niedzwiecki, N. Chao, D. Rizzieri, H.K. Lyerly, T. Clay and M.A. Morse, Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease, Cytotherapy, 10, 3, (289), (2008).
- Nobusada Koike, Shari Pilon-Thomas and James J. Mulé, Nonmyeloablative Chemotherapy Followed by T-cell Adoptive Transfer and Dendritic Cell-based Vaccination Results in Rejection of Established Melanoma, Journal of Immunotherapy, 31, 4, (402), (2008).
- Thomas A. Fleisher and João Bosco de Oliveira, Flow cytometry, Clinical Immunology, 10.1016/B978-0-323-04404-2.10097-1, (1435-1446), (2008).
- Giuseppe Guida, Antonella Vallario, Stefania Stella, Monica Boita, Paola Circosta, Sara Mariani, Giuseppina Prato, Enrico Heffler, Roberta Bergia, Antonino Sottile, Giovanni Rolla and Alessandro Cignetti, Clonal CD8+ TCR-Vβ expanded populations with effector memory phenotype in Churg Strauss Syndrome, Clinical Immunology, 10.1016/j.clim.2008.03.505, 128, 1, (94-102), (2008).
- Walter J Storkus and Louis D Falo, A 'good death' for tumor immunology, Nature Medicine, 13, 1, (28), (2007).
- Claudia Wrzesinski, Chrystal M. Paulos, Luca Gattinoni, Douglas C. Palmer, Andrew Kaiser, Zhiya Yu, Steven A. Rosenberg and Nicholas P. Restifo, Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8+ T cells, Journal of Clinical Investigation, 117, 2, (492), (2007).
- Giovanni Rolla, Giuseppe Guida and Enrico Heffler, Churg–Strauss syndrome: still a clinical challenge, Expert Review of Clinical Immunology, 10.1586/1744666X.3.6.833, 3, 6, (833-837), (2014).
- Neil L. Berinstein, Enhancing cancer vaccines with immunomodulators, Vaccine, 25, (B72), (2007).
- Claudio Anasetti and James J. Mulé, To ablate or not to ablate? HSCs in the T cell driver’s seat, Journal of Clinical Investigation, 117, 2, (306), (2007).
- Hiroto Egawa, Shingi Uemoto, Yasutugu Takada, Kazue Ozawa, Satoshi Teramukai, Hironori Haga, Mureo Kasahara, Kouhei Ogawa, Hiroshi Sato, Masako Ono, Kenji Takai, Masanori Fukushima, Kayo Inaba and Koichi Tanaka, Initial steroid bolus injection promotes vigorous CD8+ alloreactive responses toward early graft acceptance immediately after liver transplantation in humans, Liver Transplantation, 13, 9, (1262-1271), (2007).
- Yukai He, David Munn and Louis D Falo Jr, Recombinant lentivector as a genetic immunization vehicle for antitumor immunity, Expert Review of Vaccines, 10.1586/14760584.6.6.913, 6, 6, (913-924), (2014).
- Pawel Muranski, Andrea Boni, Claudia Wrzesinski, Deborah E Citrin, Steven A Rosenberg, Richard Childs and Nicholas P Restifo, Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?, Nature Clinical Practice Oncology, 3, 12, (668), (2006).
- Luca Gattinoni, Christopher A. Klebanoff and Nicholas P. Restifo, Paths to stemness: building the ultimate antitumour T cell, Nature Reviews Cancer, 10.1038/nrc3322, 12, 10, (671-684), (2012)., (2012).
- Sjoerd H. van der Burg, Ramon Arens, Ferry Ossendorp, Thorbald van Hall and Cornelis J. M. Melief, Vaccines for established cancer: overcoming the challenges posed by immune evasion, Nature Reviews Cancer, 10.1038/nrc.2016.16, 16, 4, (219-233), (2016)., (2016).
- Luca Gattinoni, Enrico Lugli, Yun Ji, Zoltan Pos, Chrystal M Paulos, Máire F Quigley, Jorge R Almeida, Emma Gostick, Zhiya Yu, Carmine Carpenito, Ena Wang, Daniel C Douek, David A Price, Carl H June, Francesco M Marincola, Mario Roederer and Nicholas P Restifo, A human memory T cell subset with stem cell–like properties, Nature Medicine, 10.1038/nm.2446, 17, 10, (1290-1297), (2011)., (2011).
